Literature DB >> 16818737

Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination.

David Masopust1, Sang-Jun Ha, Vaiva Vezys, Rafi Ahmed.   

Abstract

Heterologous prime-boost vaccination results in increased frequencies of memory T cells. Although these quantitative effects of reexposure to Ag are well documented, little is known about the impact of boosting on the functional qualities of memory T cells. To address this critical issue, we have used three different types of immunization regimens and examined how boosting effects the function and anatomic location of memory CD8 T cells. We found that memory T cell phenotype differed substantially depending on the number of immunizations and that secondary and tertiary responses resulted in the generation of memory CD8 T cells that retained effector-like properties and showed preferential accumulation in nonlymphoid tissues. These results show that memory differentiation is coupled to the history of Ag experience and that prime-boost vaccination strategies have important consequences on memory CD8 T cell quality and surveillance within mucosal tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818737     DOI: 10.4049/jimmunol.177.2.831

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  167 in total

1.  Perforin plays an unexpected role in regulating T-cell contraction during prolonged Listeria monocytogenes infection.

Authors:  Nathan W Schmidt; Aaruni Khanolkar; Lisa Hancox; Jonathan W Heusel; John T Harty
Journal:  Eur J Immunol       Date:  2012-01-18       Impact factor: 5.532

2.  Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.

Authors:  Rekha Singh; Alan L Rothman; James Potts; Farshad Guirakhoo; Francis A Ennis; Sharone Green
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 3.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

4.  Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells.

Authors:  Nikhil S Joshi; Weiguo Cui; Claudia X Dominguez; Jonathan H Chen; Timothy W Hand; Susan M Kaech
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

5.  Division-linked generation of death-intermediates regulates the numerical stability of memory CD8 T cells.

Authors:  Jeffrey C Nolz; Deepa Rai; Vladimir P Badovinac; John T Harty
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

6.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 7.  Generation, persistence and plasticity of CD4 T-cell memories.

Authors:  Jason R Lees; Donna L Farber
Journal:  Immunology       Date:  2010-05-10       Impact factor: 7.397

Review 8.  The persistence of T cell memory.

Authors:  Mark A Daniels; Emma Teixeiro
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

9.  Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice.

Authors:  Hua Li; Steven Tuyishime; Te-Lang Wu; Wynetta Giles-Davis; Dongming Zhou; Weidong Xiao; Katherine A High; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2010-12-14       Impact factor: 11.454

10.  Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.

Authors:  Katherine A Richards; Francisco A Chaves; Shabnam Alam; Andrea J Sant
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.